Mythili Koneru - Feb 27, 2023 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Chief Medical Officer
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Stock symbol
MRKR
Transactions as of
Feb 27, 2023
Transactions value $
$0
Form type
4
Date filed
3/1/2023, 03:51 PM
Previous filing
Feb 22, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Employee Stock Option (right to buy) Award $0 +51.9K $0.00 51.9K Feb 27, 2023 Common Stock 51.9K $2.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a four year period commencing on March 27, 2023 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.